These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 11457752)

  • 1. JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion.
    Mascareno E; El-Shafei M; Maulik N; Sato M; Guo Y; Das DK; Siddiqui MA
    Circulation; 2001 Jul; 104(3):325-9. PubMed ID: 11457752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The functional role of the JAK-STAT pathway in post-infarction remodeling.
    El-Adawi H; Deng L; Tramontano A; Smith S; Mascareno E; Ganguly K; Castillo R; El-Sherif N
    Cardiovasc Res; 2003 Jan; 57(1):129-38. PubMed ID: 12504822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT signaling in ischemic heart: a role of STAT5A in ischemic preconditioning.
    Yamaura G; Turoczi T; Yamamoto F; Siddqui MA; Maulik N; Das DK
    Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H476-82. PubMed ID: 12860560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between the cardiac renin angiotensin system and JAK-STAT signaling: role in cardiac hypertrophy, ischemia/reperfusion dysfunction, and heart failure.
    Booz GW; Day JN; Baker KM
    J Mol Cell Cardiol; 2002 Nov; 34(11):1443-53. PubMed ID: 12431443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction.
    Negoro S; Kunisada K; Tone E; Funamoto M; Oh H; Kishimoto T; Yamauchi-Takihara K
    Cardiovasc Res; 2000 Sep; 47(4):797-805. PubMed ID: 10974228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct components of Janus kinase/signal transducer and activator of transcription signaling pathway mediate the regulation of systemic and tissue localized renin-angiotensin system.
    Guo Y; Mascareno E; Siddiqui MA
    Mol Endocrinol; 2004 Apr; 18(4):1033-41. PubMed ID: 14726487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats.
    Omura T; Yoshiyama M; Ishikura F; Kobayashi H; Takeuchi K; Beppu S; Yoshikawa J
    J Mol Cell Cardiol; 2001 Feb; 33(2):307-16. PubMed ID: 11162135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of STAT3 in ischemic preconditioning.
    Hattori R; Maulik N; Otani H; Zhu L; Cordis G; Engelman RM; Siddiqui MA; Das DK
    J Mol Cell Cardiol; 2001 Nov; 33(11):1929-36. PubMed ID: 11708838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
    Banes AK; Shaw S; Jenkins J; Redd H; Amiri F; Pollock DM; Marrero MB
    Am J Physiol Renal Physiol; 2004 Apr; 286(4):F653-9. PubMed ID: 14678947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes.
    McWhinney CD; Dostal D; Baker K
    J Mol Cell Cardiol; 1998 Apr; 30(4):751-61. PubMed ID: 9602424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Jak/STAT signaling in heart tissue renin-angiotensin system.
    Mascareno E; Siddiqui MA
    Mol Cell Biochem; 2000 Sep; 212(1-2):171-5. PubMed ID: 11108148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
    Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
    J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuregulin-1 activates the JAK-STAT pathway and regulates lung epithelial cell proliferation.
    Liu J; Kern JA
    Am J Respir Cell Mol Biol; 2002 Sep; 27(3):306-13. PubMed ID: 12204892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro interaction between STAT 5 and JAK 2; dependence upon phosphorylation status of STAT 5 and JAK 2.
    Flores-Morales A; Pircher TJ; Silvennoinen O; Gustafsson JA; Sanchez-Gomez M; Norstedt G; Haldosén LA; Wood TJ
    Mol Cell Endocrinol; 1998 Mar; 138(1-2):1-10. PubMed ID: 9685210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldose reductase pathway mediates JAK-STAT signaling: a novel axis in myocardial ischemic injury.
    Hwang YC; Shaw S; Kaneko M; Redd H; Marrero MB; Ramasamy R
    FASEB J; 2005 May; 19(7):795-7. PubMed ID: 15746188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway.
    Duan W; Yang Y; Yan J; Yu S; Liu J; Zhou J; Zhang J; Jin Z; Yi D
    Basic Res Cardiol; 2012 May; 107(3):263. PubMed ID: 22466958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
    Frasor J; Barkai U; Zhong L; Fazleabas AT; Gibori G
    Mol Endocrinol; 2001 Nov; 15(11):1941-52. PubMed ID: 11682625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.
    Le MN; Kohanski RA; Wang LH; Sadowski HB
    Mol Endocrinol; 2002 Dec; 16(12):2764-79. PubMed ID: 12456798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of JAK/STAT pathway in IL-6-induced activation of vascular smooth muscle cells.
    Watanabe S; Mu W; Kahn A; Jing N; Li JH; Lan HY; Nakagawa T; Ohashi R; Johnson RJ
    Am J Nephrol; 2004; 24(4):387-92. PubMed ID: 15256805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
    Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
    Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.